ArticleOpen forum infectious diseases2022

Real-Life Effectiveness and Safety of Baricitinib as Adjunctive to Standard-of-Care Treatment in Hospitalized Patients With Severe Coronavirus Disease 2019.

Nikolaos Tziolos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.